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Background: The role of several cardiogenic risk factors, including patent foramen ovale, in patients with 
cryptogenic  stroke  has  been  extensively  studied.  However,  little  attention  has  been  paid  to  the  role  of 
non-cardioembolic causes of cryptogenic stroke. We therefore sought to identify the characteristics of cryptogenic 
stroke. 
Methods: We studied 832 patients with acute infarction in the middle cerebral arterial territory. We divided the 
patients into four subtypes: 402 with large artery atherosclerosis (LAA), 133 with cardioembolism, 182 with small 
arterial occlusion (SAO), and 115 with cryptogenic stroke. We compared risk factors and lesion patterns observed 
by diffusion-weighted imaging (DWI) between patients with cryptogenic stroke and those with stroke of other 
subtypes.
Results: Both risk factors and DWI lesion patterns differed between the cryptogenic and cardioembolic groups 
(P<0.05). Risk factors for cryptogenic stroke were similar to those for the LAA and SAO groups. Similarly, DWI 
lesion patterns for cryptogenic stroke were similar to LAA patients. Large cortical infarcts on DWI were more 
common in the cardioembolic group than in the LAA or cryptogenic groups (P<0.001). In contrast, deep, non-lacunar 
(OR 5.02; 95% CI 2.68～9.40; P<0.001) and superficial perforator infarcts (OR 2.23; 95% CI 1.08～4.59; P=0.029) were 
independently associated with the cryptogenic group.
Conclusions: Our results indicate that non-cardioembolic causes, such as macro- and microangiopathy, are 
important mechanisms in the pathogenesis of cryptogenic stroke.
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INTRODUCTION
Approximately 40% of ischemic strokes have no 
clearly defined etiology after extensive work-up; 
these are termed cryptogenic strokes.
1 Knowledge of the 
clinical and radiological features of cryptogenic strokes 
will help physicians understand the pathogenic 
mechanisms involved in stroke development. This 
information is essential for focused planning and 
implementation of primary and secondary prevention 
programs in patients with cryptogenic stroke.
The pattern of lesions identified by diffusion-weighted 
imaging (DWI) has been correlated with the underlying 
pathogenic mechanisms of stroke, e.g., multiple acute 
lesions in strokes of presumed embolic origin
2 and 
internal border zone infarcts in patients with hemo-
dynamic impairment due to large arterial disease.
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addition, DWI lesion patterns are associated with 
specific causes of stroke.
5-6 However, data on the clinical 
and DWI features in patients with cryptogenic stroke 
have not yet been reported.
Recently, the roles of several cardiogenic risk factors, 
including patent foramen ovale (PFO), and mitral valve 
prolapse, have been extensively studied. However, little 
attention has been paid to the role of non-cardioembolic 
causes in the development of cryptogenic stroke. We 
hypothesized that non-cardioembolic mechanisms, such 
as macro- and microangiopathy, as well as the above 
cardioembolic risk factors may take an important part in 
the development of cryptogenic stroke.
In this study, we sought to identify the stroke 
characteristics of patients with cryptogenic stroke. We 
conducted a comparative study of radiological features 
and inflammatory factors, as well as conventional stroke 
risk factors, in patients with cryptogenic stroke and those 
with stroke due to other documented causes.
MATERIALS AND METHODS
Patient selection
From January 2001 to October 2004, we prospectively 
studied consecutive patients with acute symptomatic 
middle cerebral artery (MCA) infarction who were 
admitted to the department of Neurology at Ajou 
University Hospital, Korea. Patients were identified as 
those who had suffered from focal symptoms, had been 
observed within 7 days of symptom onset, and showed 
relevant DWI lesions within the area of the MCA 
distribution. All patients gave their consent with regard 
to participating in the study. We excluded patients with 
(a) other determined causes of stroke such as carotid 
dissection, hypercoagulable state, vasculitis, and 
complicated migraine (n=42), (b) two or more causes of 
stroke (n=26), and (c) incomplete work-ups (n=35). Of 
1,577 stroke patients who were admitted during the 
study period, 832 patients were included in the final 
analysis; 484 (58%) were men and 348 (42%) were 
women, with a mean age of 62.3±12.7 years (range, 
31-95 years).
Work-up
Patients were evaluated according to a protocol that 
included demographic data, medical history, vascular 
risk factors, and the National Institute of Health Stroke 
Scale (NIHSS) score, as in our previous study.
7 Both 
T2-weighted imaging and DWI were performed using a 
1.5T clinical magnetic resonance imaging (MRI) system. 
All patients underwent diagnostic testing, including 
vascular studies, echocardiography, electrocardiography, 
and routine blood tests. The degree of stenosis was 
measured as described in our previous study.
7 Hemostatic 
markers of prothrombotic tendencies, including protein 
C, protein S, antithrombin III, and antiphospholipid 
antibodies (lupus anticoagulant and anticardiolipin IgG 
and IgM) were checked in all patients <50 years of age. 
 Based on their clinical syndromes, infarct sizes on 
DWI, and results of vascular and cardiological studies, 
we divided the patients into four groups: (1) patients 
with non-lacunar syndrome, larger DWI lesions (≥15 
mm), and occlusive lesions on vascular studies [large 
artery atherosclerosis (LAA) group]; (2) patients who 
presented with clinical and DWI findings similar to the 
LAA group but who also showed signs of cardio-
embolism (CE group); (3) patients with traditional 
lacunar syndrome and symptomatic, small, deep infarcts 
on DWI and no arterial occlusion [small arterial 
occlusion (SAO) group]; and (4) patients with non- 
lacunar syndrome or larger DWI lesions but no sign of 
cardioembolism or arterial occlusion (cryptogenic group). 
Potential sources of cardioembolism were defined as 
atrial fibrillation, mitral stenosis, prosthetic valves, 
myocardial infarction within 6 weeks, intracardiac clot, 
ventricular aneurysm, and bacterial endocarditis; lacunar 
syndrome as one of the five traditional lacunar 
syndromes (pure motor hemiplegia, pure sensory stroke, 
sensory-motor stroke, ataxic hemiparesis, and dysarthria 
clumsy hand syndrome); and an occlusive lesion as 
stenosis of greater than 50% or occlusion on the large 
intracranial vessels and the internal carotid artery. 
Digital subtraction angiography was performed in 174 
patients, magnetic resonance angiogram in 498 patients, 
and computed tomographic angiogram in 160 patients.
In this study, we additionally performed transeso-Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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Figure 1. DWI lesion patterns.
phageal echocardiography (TEE) and/or Holter monitoring 
to detect paroxysmal atrial fibrillation, if the patient had 
one of the following characteristics: past vascular events, 
such as deep venous thrombosis, or pulmonary embolism; 
palpitations preceding or accompanying stroke onset; or 
peripheral vascular insufficiency, deep vein thrombosis, 
or pulmonary embolism.
DWI lesion patterns
Based on observed DWI patterns, patients were 
grouped as follows: (1) territorial infarcts involving two 
or more subdivisions; (2) cortical infarcts involving one 
subdivision; (3) multiple, small cortical infarcts; (4) 
borderzone infarcts, either cortical or internal; (5) single 
or multiple superficial infarcts in the centrum ovale; (6) 
small, deep infarcts; and (7) other deep infarcts, i.e., 
large striatocapsular lesions or concomitant DWI lesions 
outside the striatocapsular area (Fig. 1). The MCA 
territory was divided into three subdivisions, i.e., deep, 
superior, and inferior, according to the scheme 
previously reported.
8 Small cortical or centrum ovale 
infarcts were defined as DWI lesions <1 cm in diameter, 
and small, deep infarcts were defined as striatocapsular 
lesions <1.5 cm. Analysis of the DWI data was carried 
out by two readers (S.H.Y. and P.H.L.) blinded to the 
clinical data, and inter-observer agreement was 91%. 
The opinion of a third reader (S.R.Y.) was obtained in 
cases of disagreement.
Conventional and novel risk factors for stroke
Hypertension was defined as systolic blood pressure 
>160 mmHg and/or diastolic blood pressure >95 mmHg 
on two different occasions, before or 1 week after stroke 
onset, or the use of antihypertensive medication; diabetes 
mellitus was defined as fasting glucose >140 mg/dl or 
the use of antidiabetic medication; hyperlipidemia was 
defined as fasting serum cholesterol >240 mg/dl and/or 
fasting serum triglyceride levels >200 mg/dl or the use Bang OY, et al. Non-cardioembolic mechanisms in Cryptogenic Stroke 
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Mechanism of stroke
P Cryptogenic 
(n=115)
LAA
(n=402)
CE
(n=133)
SAO
(n=182)
Age (years)
Male sex
NIHSS score
62.1±12.7
61 (54%)
3.1±3.3
63.0±12.2
234 (58%)
4.7±4.8*
66.2±12.9*
81 (61%)
7.1±5.7*
61.3±11.5
107 (59%)
2.8±2.9
 0.004
 0.731
<0.001
Risk factors
Hypertension
Diabetes
Hyperlipidemia
Smoking
Previous stroke history
Previous CAOD history
C-reactive protein, mg/dl
Fibrinogen, mg/dl
D-dimer, µg/ml
65 (57%)
42 (37%)
27 (24%)
47 (41%)
26 (23%)
4 (4%)
0.59±1.10
368.9±123.4
0.73±1.61
251 (62%) 
131 (33%)
93 (23%)
149 (37%)
116 (29%)
37 (9%)*
0.47±0.93
378.7±117.5 
0.88±1.82
61 (46%)
21 (16%)*
15 (12%)*
36 (27%)*
27 (21%)
24 (18%)*
0.75±1.30
386.7±130.2
0.76±1.27
111 (61%)
41 (23%)*
37 (20%)
84 (46%)
36 (20%)
9 (5%)
0.30±0.47*
366.0±117.3
0.84±2.37
 0.01
<0.001
 0.032
 0.007
 0.054
<0.001
 0.005
 0.534
 0.875
* differ from cryptogenic stroke, P<0.05.
Table 1. General characteristics of the study population
of antihyperlipidemia medications; cigarette smoking 
was defined as smoking at the time of the stroke; and 
previous stroke was identified by patient history, 
neurological examination, and laboratory tests.
Serum levels of C-reactive protein (CRP) and 
fibrinogen were evaluated as inflammatory markers, 
whereas the D-dimer level was checked as a hemostatic 
marker of ischemic stroke subtypes.
9-10 These levels 
were evaluated in 687 patients (82.6%) who enrolled 
between August 2002 and October 2004. Peripheral 
blood samples were drawn from each patient at the time 
of admission (1.6±2.1 days after symptom onset). 
Patients in which CRP levels were >10 mg/dl were 
excluded because of possible coexistent infection 
(N=29).
Statistical analysis
Differences between the groups were examined using 
the Chi-square test, Student t-test, or one-way ANOVA 
with post-hoc analysis. Multiple logistic regression 
analysis was conducted to determine whether any DWI 
lesion patterns were independently associated with 
cryptogenic stroke, over and above the age and sex of 
the patient, initial stroke severity, or stroke risk factors. 
Those that were significant at the 0.2 level were entered 
into the initial multivariate model. When the most 
parsimonious model was obtained by backward stepwise 
elimination of the non-significant factors, each of the 
excluded variables was again entered separately into the 
model to test its contribution to the final model. Results 
are given as OR estimates of relative risk, with 95% CI. 
Statistical significance was established at the P<0.05 
level.
RESULTS
According to the clinical, DWI, angiographic, and 
cardiological findings, 402 patients were classified in the 
LAA group, 133 in the CE group, 182 in the SAO 
group, and 115 in the cryptogenic group.
As shown in Table 1, the clinical features and risk 
factors of the cryptogenic group were more similar to 
those of the LAA and SAO groups than to the CE 
group, especially in terms of age, and the presence of 
diabetes, hyperlipidemia, or smoking habits.
Total 45 patients underwent extensive cardiologic Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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Figure 2. DWI lesion patterns in 
each stroke subtype.
work-up; TEE or Holter monitoring. Fourteen patients 
showed abnormalities: PFO with/without atrial septal 
defect (n=8), aortic arch atheroma (n=1), paroxysmal 
atrial fibrillation (n=3), and left atrium thrombus (n=2). 
In contrast, about 40% of patients in the cryptogenic 
group had stenosis other than significant stenosis of the 
relevant artery (>50% stenosis of non-relevant vessels or 
mild stenosis [30~50%] of relevant vessels). The 
frequency of significant stenosis of non-relevant vessels 
of the cryptogenic group were intermediate (27 patients; 
23.5%); higher than that of the CE group (23 patients; 
17.3%) or SAO group (27 patients; 14.9%) but lower 
than that of the LAA group (143 patients; 35.6%).
The DWI data showed that the lesion pattern in 
patients with cryptogenic stroke was similar to that of 
patients in the LAA group (Fig. 2). In the CE group, 
large cortical infarcts, either territorial (31%) or cortical 
infarcts involving one subdivision of the MCA territory 
(35%), were the most frequent type of DWI patterns, 
whereas border zone infarcts were rarely observed in 
these patients (2 of 133 patients; 1.5%).
Other deep infarcts on DWI were significantly more 
prevalent in patients with cryptogenic stroke than in 
those of the other groups (P<0.001). The frequency of 
large cortical infarcts in the cryptogenic group was 
similar to the LAA group (P=0.451) but differed from 
the CE or SAO group (P<0.01 for both). The frequency 
of superficial perforator infarcts was similar in the 
cryptogenic and LAA groups (P=0.389) but was lower 
in the CE and SAO groups (P<0.05 for both).
Among the cryptogenic group, the DWI patterns in 
patients <50 years old were similar to those in patients 
aged 50 or older (Fig. 3). However, the DWI lesion 
patterns differed depending on the time of the vascular 
study (Fig. 4). In cases that the vascular study was 
delayed, the DWI data showed the characteristics of the 
LAA group; the frequency of DWI lesion patterns of 
superficial perforator infarcts was higher and that of 
large cortical infarcts was lower when the vascular study 
was conducted after 12 hours of symptom onset than 
Figure 3. DWI lesion patterns depending on the age of symptom
onset in patients with cryptogenic stroke.Bang OY, et al. Non-cardioembolic mechanisms in Cryptogenic Stroke 
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Figure 4. DWI lesion patterns 
depending on the time of vascular 
study in patients with cryptogenic 
stroke (left) and atherosclerotic 
stroke (right).
Variables
Cryptogenic stroke*
OR (95% CI) P
Age
Sex
N/A
N/A
 0.910
 0.350
Risk factors
Hypertension
Diabetes
Smoking
Hyperlipidemia
Previous stroke history
Previous CAOD history
C-reactive protein
Fibrinogen
D-dimer
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
 0.141
 0.870
 0.970
 0.229
 0.203
 0.281
 0.060
 0.589
 0.713
The NIHSS score
Time of work-up
0.902 (0.822-0.988)
N/A
 0.027
 0.830
DWI lesion patterns 
Territorial
Cortical involving 
  one subdivision
Borderzone
Multiple small cortical 
Superficial perforator
Other deep
N/A
N/A
N/A
N/A
2.231 (1.084-4.591)
5.020 (2.681-9.401)
 0.852
 0.230
 0.659
 0.189
 0.029
<0.001
*Compared to those with non-cryptogenic stroke group.
N/A; not applicatable
Table 2. Multiple logistic regression test when it was conducted within 12 hours. Such trend was 
also observed in patients of the LAA group (Fig. 4).
Certain DWI lesion patterns specific to the 
cryptogenic group were observed; cryptogenic stroke 
was prevalent in patients who showed other deep 
infarcts (31%) or superficial perforator infarcts (23%). 
Such DWI lesion patterns were independently associated 
with the cryptogenic group after adjustment for other 
risk factors. Table 2 shows the results of multiple 
logistic regression analysis and the OR for each factor. 
Patients with other deep and superficial perforator 
infarcts were 5 and 2.2 times more likely to have neither 
significant vascular stenosis nor potential sources of 
cardioembolism, respectively. The NIHSS score at 
admission was associated with cryptogenic stroke; the 
milder the neurological deficit, the more likely 
physicians failed to document the cause of stroke.
DISCUSSION
Cardioembolic risk factors in cryptogenic stroke
Recurrence rate and mortality following ischemic 
stroke are high; therefore, great efforts are made to 
prevent stroke recurrence. The list of clinical risk factors 
for ischemic stroke continues to grow. Recently, risk 
factors such as PFO, atrial septal aneurysm, 
inflammatory markers such as CRP, hyperhomo-Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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cysteinemia, and aorta atherosclerosis have been newly 
implicated. TEE and Holter monitoring have become 
routine procedures in evaluating stroke patients, 
especially those with cryptogenic stroke. However, the 
impact of such routine procedures should be addressed 
in terms of cost-effectiveness.
Recently, PFO, aortic arch atheroma, and paroxysmal 
atrial fibrillation have been reported to be risk factors 
for cardioembolic stroke, especially in patients with 
cryptogenic stroke.
11-14 However, their relationship to 
stroke occurrence, their prognosis, and the therapeutic 
implications are not clearly established. First, because of 
high prevalence of PFO in the normal population, 
detection of PFO in stroke patients does not necessarily 
identify it as the cause of stroke.
15 Second, the optimal 
treatment in patients with PFO remains undetermined.
16 
Third, evidence regarding the therapeutic and prognostic 
values of Holter monitoring to detect paroxysmal atrial 
fibrillation is limited and remains inconclusive.
17-18
The role of atherosclerosis in the development of 
cryptogenic stroke
Our results on risk factor profiles show that the 
cryptogenic group shared characteristics with the LAA 
and SAO groups, rather than with the CE group. In the 
present study, patients with cryptogenic stroke were in 
an atherosclerosis-prone condition. Their risk factor 
profiles may differ from those in patients with PFO or 
paroxysmal atrial fibrillation. PFO is associated with 
cryptogenic stroke in young adults, who are less likely 
to have traditional risk factors for stroke.
11,19
In agreement with previous computed tomography 
data,
6 our DWI data show that different infarct patterns 
depend on stroke subtypes. The DWI lesion patterns of 
our patients with cryptogenic stroke were similar to 
those in patients with LAA, and large cortical infarcts 
(20%) or concomitant basilar arterial territory infarcts 
(2.6%) were relatively rare in these patients. It has been 
reported that stroke in association with PFO occurs 
commonly in the pial convexity branches, as expected, 
as well as in the basilar artery distribution area, but 
rarely in the deep brain structures.
11,20-21 In addition, it 
is possible that spontaneous recanalization occurred 
during the subacute phase of ischemic stroke in the 
cryptogenic group. The DWI lesion pattern was even 
more similar to the LAA group in patients who 
underwent vascular studies 12 hours after symptom onset 
compared to those examined within 12 hours.
We recently reported a high rate of recurrence in 
patients with cryptogenic stroke, similar to patients with 
LAA.
7 The annual rate of recurrence in cryptogenic 
stroke patients with cardioembolic risks, such as PFO, is 
low (1.2~2.4%).
22 Atherosclerosis may be responsible for 
the recurrence of cryptogenic stroke because recurrence 
is associated with mild stenosis (≤50%) of the relevant 
artery or >50% stenosis of a non-relevant artery.
7 
The role of microangiopathy in the development of 
cryptogenic stroke
In this study, the DWI lesion pattern of other deep 
infarcts was the most predominant one observed in 
cryptogenic stroke. Although one-third was associated 
with mild stenosis (≤50%) of the relevant artery or 
>50% stenosis of a non-relevant artery, the remainder 
had normal angiographic results. Microangiopathy may 
play an important role in the latter group. Although 
several studies have selected a diameter of 20 mm as the 
cutoff point of lacunae, most using DWI or conventional 
MRI have used 15 mm as the size criterion. The 
conventional 15-mm criterion for lacunae based on DWI 
may underestimate the diagnosis of SAO as it was 
suggested.
5 Further studies are needed to confirm which 
diameter-criterion should be accepted for the diagnosis 
of SAO.
Reasons for differences in the risk factors for 
cryptogenic stroke among studies
The difference in characteristics of cryptogenic stroke 
patients among studies may be due to small numbers of 
patients as well as different depth of patient evaluation, 
such as TEE or Holter monitoring. However, differences 
may also be explained by the high prevalence of 
intracranial atherosclerosis and SAO and low prevalence 
of cardioembolic factors in Asians. Little is known about 
the distribution of the latter among Asians with Bang OY, et al. Non-cardioembolic mechanisms in Cryptogenic Stroke 
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cryptogenic stroke. Most of the studies looking for 
potential sources of cardioembolism and its association 
with ischemic stroke have been done in Caucasians or 
small groups of African-American patients, thus making 
it difficult to assess and compare the existing risk factor 
burden for ischemic stroke between other ethnic groups 
and Asians. However, as with African-Americans, there 
may be differences between Caucasians and Asians with 
regard to prevalence of right-to-left cardiac shunt (i.e., 
PFO), thrombogenic sources (i.e., venous thrombosis), 
atrial fibrillation, and aortic arch atheroma.
23-25
Limitations and conclusions
Our study has several limitations. Although TTE was 
performed in all patients, more extensive studies should 
be conducted to document possible embolism in patients 
with cryptogenic stroke. In this study, about 30% of 
patients who underwent extensive cardiologic work-up 
showed abnormalities. Therefore, it should be done if 
the patient was clinically suspected to have potential 
sources of cardioembolism. However, our study does not 
support the use of TEE and Holter monitoring as routine 
procedures in evaluating cryptogenic stroke patients, 
because the role of uncommon causes of embolism 
might have played a small part in our study. Further 
population-based studies with long-term follow-up and 
more extensive work-up to document possible causes of 
embolism are needed. 
Our study does not show that cardioembolic stroke 
from PFO or paroxysmal atrial fibrillation is an 
important pathogenic mechanism in cryptogenic stroke. 
It should be stressed, however, that non-cardiogenic 
mechanisms such as LAA and SAO are equally as 
important in the pathogenesis of cryptogenic stroke as 
cardiogenic risk factors such as PFO or paroxysmal 
atrial fibrillation.
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